EQT acquired a majority stake in McGill and Partners for $2 billion, taking control of the London specialty broker from Warburg Pincus. The transaction marks the third ownership change for McGill since 2020, when Warburg first backed the firm's spinout from Jardine Lloyd Thompson. EQT's move follows market chatter around KKR's reported $17 billion exit from insurance broker USI, a deal that would rank among the largest insurance services exits on record.
McGill operates in the specialty and reinsurance brokerage space, a segment that has drawn sustained allocator attention since 2018. The firm handles complex placements — aviation, marine, political risk — where margin compression has been slower than in standard commercial lines. Warburg's hold period was roughly four years. EQT is paying a price that industry participants estimate at 12-14x trailing EBITDA, consistent with recent insurance broker multiples but above the 9-11x range common in 2021. The valuation reflects compressed spread between top-quartile specialty brokers and the broader insurance distribution universe.
The pattern is clear: insurance brokers have become a preferred vehicle for financial engineering in a zero-sum attention economy. Brokers generate recurring revenue with limited capital intensity, making them ideal for leverage. EQT's entry suggests the firm sees runway in specialization, even as capacity floods into standard lines. The timing is worth noting. McGill's sale comes as specialty reinsurance pricing begins to flatten after two years of hardening. If EQT intends to sell in 2028 or 2029, it will need margin expansion from bolt-on acquisitions or operational tightening, not rate tailwinds.
The insurance broker roll-up thesis has now lasted longer than most observers expected. Since 2019, private equity has deployed over $60 billion into the channel, treating brokers as infrastructure plays rather than cyclical assets. The logic: brokers sit between capacity and demand, extracting fees regardless of underwriting outcomes. The risk is that the strategy has become consensus. When KKR's USI exit closes, it will crystallize returns that later entrants cannot replicate without multiple expansion or aggressive cost-cutting. EQT is betting that specialty brokers remain differentiated, but the window for differentiation narrows with each transaction.
Allocators should watch three developments. First, whether KKR prices USI above $17 billion or retreats on valuation as interest rates remain elevated. That exit will set the comp for every insurance services deal in 2025. Second, whether EQT begins bolt-on acquisitions within six months, signaling a build-and-flip strategy rather than a long hold. Third, whether Warburg recycles proceeds into another insurance platform, which would confirm that the firm views this as a durable vertical rather than a single-cycle trade. Each of these will clarify whether insurance brokers remain a structural opportunity or have entered late-cycle repricing.
EQT's $2 billion bet is not a contrarian move. It is a vote that the music continues and that specialty brokers can still deliver mid-teens IRRs in a 6% discount rate environment. The firm's edge, if it exists, lies in European distribution and cross-border reinsurance placements. If those advantages compress, the exit will require either a corporate buyer or another sponsor willing to underwrite slower growth. That is a 2028 question, but the 2025 answer is that private equity still believes insurance distribution prints cash faster than most alternatives.